Publication
Erratum: Intracellular activation of a prostate specific antigen-cleavable doxorubicin prodrug: A key feature toward prodrug-nanomedicine design (Molecular Pharmaceutics (2019) 16:4 (1573-1585) DOI:10.1021/acs.molpharmaceut.8b01257)
Pereira, S. G. T., Hudoklin, S., Kreft, M. E., Kostevsek, N., Stuart, M. C. A. & Al-Jamal, W. T., 3-Aug-2020, In : Molecular pharmaceutics. 17, 8, p. 3149-3149 1 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
In the original document, the chemical structure of the PSA-cleavable peptide on page 1574 was (glutaryl-4-Hyp-AlaSer-Chg-Gln-Ser-Leu-OH). The correct chemical structure is ((MeO2C-C-(CH2)3-CO-4-Hyp-Ala-Ser-Chg-Gln-Ser-Leu-OH). In the original document, the chemical structure of PSAcleavable peptide (Figure 1A) on page 1576 is shown: The correct chemical structure in Figure 1A is shown. (Figure Presented).
| Original language | English |
|---|---|
| Pages (from-to) | 3149-3149 |
| Number of pages | 1 |
| Journal | Molecular pharmaceutics |
| Volume | 17 |
| Issue number | 8 |
| Publication status | Published - 3-Aug-2020 |
Related Publications
Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Towards Prodrug-Nanomedicine Design
Pereira, S. G. T., Hudoklin, S., Kreft, M. E., Kostevsek, N., Stuart, M. C. A. & Al-Jamal, W. T., Apr-2019, In : Molecular pharmaceutics. 16, 4, p. 1573-1585 13 p.Research output: Contribution to journal › Article › Academic › peer-review
ID: 132703658